169 related articles for article (PubMed ID: 37620221)
1. Follow-up care and assessment of comorbidities and complications in patients with primary aldosteronism: The clinical practice guideline of the Taiwan Society of aldosteronism.
Pan LH; Chen YY; Pan CT; Hsu CY; Tseng CS; Yen IW; Chan CK; Lin LY
J Formos Med Assoc; 2024 Mar; 123 Suppl 2():S141-S152. PubMed ID: 37620221
[TBL] [Abstract][Full Text] [Related]
2. Primary Aldosteronism: Cardiovascular Outcomes Pre- and Post-treatment.
Hundemer GL
Curr Cardiol Rep; 2019 Jul; 21(9):93. PubMed ID: 31352525
[TBL] [Abstract][Full Text] [Related]
3. Japan Endocrine Society clinical practice guideline for the diagnosis and management of primary aldosteronism 2021.
Naruse M; Katabami T; Shibata H; Sone M; Takahashi K; Tanabe A; Izawa S; Ichijo T; Otsuki M; Omura M; Ogawa Y; Oki Y; Kurihara I; Kobayashi H; Sakamoto R; Satoh F; Takeda Y; Tanaka T; Tamura K; Tsuiki M; Hashimoto S; Hasegawa T; Yoshimoto T; Yoneda T; Yamamoto K; Rakugi H; Wada N; Saiki A; Ohno Y; Haze T
Endocr J; 2022 Apr; 69(4):327-359. PubMed ID: 35418526
[TBL] [Abstract][Full Text] [Related]
4. Targeted treatment of primary aldosteronism - The consensus of Taiwan Society of Aldosteronism.
Huang KH; Yu CC; Hu YH; Chang CC; Chan CK; Liao SC; Tsai YC; Jeff Chueh SC; Wu VC; Lin YH;
J Formos Med Assoc; 2019 Jan; 118(1 Pt 1):72-82. PubMed ID: 29506889
[TBL] [Abstract][Full Text] [Related]
5. Cardiometabolic risk in patients with primary aldosteronism and autonomous cortisol secretion. Case-control study.
Araujo-Castro M; Bengoa Rojano N; Fernández Argüeso M; Pascual-Corrales E; Jiménez Mendiguchía L; García Cano AM
Med Clin (Barc); 2021 Nov; 157(10):473-479. PubMed ID: 33039136
[TBL] [Abstract][Full Text] [Related]
6. Diagnosis and management of primary aldosteronism.
Vilela LAP; Almeida MQ
Arch Endocrinol Metab; 2017; 61(3):305-312. PubMed ID: 28699986
[TBL] [Abstract][Full Text] [Related]
7. Prevalence, diagnosis and outcomes of treatment for primary aldosteronism.
Yang Y; Reincke M; Williams TA
Best Pract Res Clin Endocrinol Metab; 2020 Mar; 34(2):101365. PubMed ID: 31837980
[TBL] [Abstract][Full Text] [Related]
8. Taiwan mini-frontier of primary aldosteronism: Updating treatment and comorbidities detection.
Chan CK; Chang YY; Tsai YC; Chen ZW; Wu CY; Huang WC; Yen IW; Wu KH; Wu VC; Lin YH;
J Formos Med Assoc; 2021 Oct; 120(10):1811-1820. PubMed ID: 33906783
[TBL] [Abstract][Full Text] [Related]
9. Cortisol Excess in Patients With Primary Aldosteronism Impacts Left Ventricular Hypertrophy.
Adolf C; Köhler A; Franke A; Lang K; Riester A; Löw A; Heinrich DA; Bidlingmaier M; Treitl M; Ladurner R; Beuschlein F; Arlt W; Reincke M
J Clin Endocrinol Metab; 2018 Dec; 103(12):4543-4552. PubMed ID: 30113683
[TBL] [Abstract][Full Text] [Related]
10. [Clinical characteristics and prognosis of primary aldosteronism associated with subclinical Cushing syndrome].
Liao YY; Song Y; Hu JB; Yang SM; Zheng Y; Li QF
Zhonghua Nei Ke Za Zhi; 2024 Apr; 63(4):378-385. PubMed ID: 38561283
[No Abstract] [Full Text] [Related]
11. Bilateral co-secretory lesions presenting with coexisting Cushing syndrome and primary aldosteronism: a case report.
Gao H; Li L; Chen F; Ren Y; Chen T; Tian H
BMC Endocr Disord; 2023 Nov; 23(1):263. PubMed ID: 38017509
[TBL] [Abstract][Full Text] [Related]
12. Case detection and diagnosis of primary aldosteronism - The consensus of Taiwan Society of Aldosteronism.
Wu VC; Hu YH; Er LK; Yen RF; Chang CH; Chang YL; Lu CC; Chang CC; Lin JH; Lin YH; Wang TD; Wang CY; Tu ST; Jeff Chueh SC; Chang CC; Tseng FY; Wu KD;
J Formos Med Assoc; 2017 Dec; 116(12):993-1005. PubMed ID: 28735660
[TBL] [Abstract][Full Text] [Related]
13. Primary aldosteronism and essential hypertension: assessment of cardiovascular risk at diagnosis and after treatment.
Turchi F; Ronconi V; di Tizio V; Ceccoli L; Boscaro M; Giacchetti G
Nutr Metab Cardiovasc Dis; 2014 May; 24(5):476-82. PubMed ID: 24630976
[TBL] [Abstract][Full Text] [Related]
14. Risk of sepsis in patients with primary aldosteronism.
Chan CK; Hu YH; Chen L; Chang CC; Lin YF; Lai TS; Huang KH; Lin YH; Wu VC; Wu KD;
Crit Care; 2018 Nov; 22(1):313. PubMed ID: 30463626
[TBL] [Abstract][Full Text] [Related]
15. MANAGEMENT OF ENDOCRINE DISEASE: Diagnosis and management of primary aldosteronism: the Endocrine Society guideline 2016 revisited.
Williams TA; Reincke M
Eur J Endocrinol; 2018 Jul; 179(1):R19-R29. PubMed ID: 29674485
[TBL] [Abstract][Full Text] [Related]
16. [Diagnosis and treatment outcome in primary aldosteronism based on a retrospective analysis of 187 cases].
Szücs N; Gláz E; Varga I; Tóth M; Kiss R; Patócs A; Jakab C; Perner F; Járay J; Horányi J; Dabasi G; Molnár F; Major L; Füto L; Rácz K; Tulassay Z
Orv Hetil; 2006 Jan; 147(2):51-9. PubMed ID: 16509213
[TBL] [Abstract][Full Text] [Related]
17. Treatment of primary aldosteronism: Clinical practice guidelines of the Taiwan Society of Aldosteronism.
Tseng CS; Chan CK; Lee HY; Pan CT; Peng KY; Wang SM; Huang KH; Tsai YC; Wu VC; Chueh JS;
J Formos Med Assoc; 2024 Mar; 123 Suppl 2():S125-S134. PubMed ID: 37328332
[TBL] [Abstract][Full Text] [Related]
18. [Clinical characteristics of primary aldosteronism with concurrent adrenal Cushing's syndrome].
Guo JC; Chen XY; Zhang JQ; Guo XH
Zhonghua Yi Xue Za Zhi; 2020 Sep; 100(36):2828-2833. PubMed ID: 32988142
[No Abstract] [Full Text] [Related]
19. RAS-challenge as a first-look test for detection of primary aldosteronism in patients with treatment-resistant hypertension.
Beger C; Karg T; Hinrichs JB; Ringe B; Haller H; Meyer BC; Limbourg FP
Blood Press; 2023 Dec; 32(1):2179340. PubMed ID: 36803263
[TBL] [Abstract][Full Text] [Related]
20. Selective Glucocorticoid Replacement Following Unilateral Adrenalectomy for Hypercortisolism and Primary Aldosteronism.
DeLozier OM; Dream SY; Findling JW; Carroll TB; Evans DB; Wang TS
J Clin Endocrinol Metab; 2022 Jan; 107(2):e538-e547. PubMed ID: 34558612
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
